Hospital-acquired infections (HAIs) Control Market will reach at $24.32 bn by 2032, Size, Development Data, Growth Analysis & Forecast 2022 to 2028 -STERIS Corporation, Advanced Sterilization Products Division, Hoffmann-La Roche, Pfizer, Becton Dickinson

The hospital acquired infection control market is projected to reach USD 21.3 billion by 2026 from USD 29.1 billion in 2021, at a CAGR of 1.5% during the forecast period. Hospital-acquired infections (HAIs) Control Market will reach at $24.32 bn by 2032 The growth of the hospital acquired infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental & personal hygiene due to COVID-19. The increasing use of E-beam sterilization, reintroduction of ethylene oxide sterilization, and the growing healthcare industry and outsourcing of operation to emerging countries are expected to offer high-growth opportunities for market players during the forecast period.
Some of the Major Key players profiled in the study are STERIS Corporation, Advanced Sterilization Products Division, Hoffmann-La Roche, Pfizer, Becton Dickinson

Get PDF Sample Report + All Related Table and Graphs @: https://www.mraccuracyreports.com/report-sample/379871

Restraint: Concerns regarding the safety of reprocessed instruments
Healthcare providers reprocess reusable medical devices to save money and reduce waste. Examples of reusable medical devices include surgical forceps, endoscopes, and stethoscopes. However, there are concerns about the safety and performance of reprocessed devices. Inadequate cleaning and sterilization of instruments can result in the retention of blood, tissue, and other biological debris in reusable devices, which increases the risk of surgical-site infections (SSIs) in patients. The debris can allow microbes to survive the subsequent disinfection or sterilization process, which could then lead to HAIs. Inadequate reprocessing can also result in other adverse patient outcomes, such as tissue irritation from residual reprocessing materials such as chemical disinfectants. These factors are limiting the acceptance of reprocessing among hospital administrators and physicians.

Opportunity: Reintroduction of ethylene oxide sterilization
Ethylene oxide is one of the most effective gaseous sterilizing agents for instruments susceptible to high temperatures, such as plastic instruments and instruments with electrical components. However, the CDC has stated that chronic exposure to ethylene oxide in workplaces can cause cancer. Also, ethylene oxide sterilization can irritate the skin and mucous membranes, resulting in CNS abnormalities in humans. Similarly, acute exposure to EtO gas may result in respiratory irritation, lung injury, headache, nausea, vomiting, diarrhea, shortness of breath, and cyanosis. EtO also degrades in the atmosphere by reacting with photochemically produced hydroxyl radicals. Authorities in several countries have defined regulatory frameworks to govern EtO usage in specific sterilization applications. In December 2016, the US Environmental Protection Agency (EPA), under the Integrated Risk Information System (IRIS) Assessment Program, declared ethylene oxide a probable human carcinogen. The European Union has already banned the use of ethylene oxide for any food fumigation due to safety and environmental concerns. The use of EtO for sterilizing ground spices is forbidden in the US.
Global Hospital-acquired infections (HAIs) Control Market Segmentation:

Hospital-acquired infections (HAIs) Control Segmentation by Type:

Diagnostic techniques, Dleaning and sterilization, Treatment.

Hospital-acquired infections (HAIs) Control Segmentation by Application:

General Hospital, Infectious Disease Hospital

Key market aspects are illuminated in the report:

How Will Rise in Surgical Procedures Impact Sales of Hospital Acquired Infection Control Equipment?
Globally, the number of surgical procedures performed every year has been increasing substantially and is expected to reach a new high by the end of the decade. The risk of healthcare-associated infections is also predicted to rise as demand for surgical instruments increases with rising number of surgical procedures performed.

Rising awareness about the effectiveness of sterilised and disinfected medical instruments and devices is a key factor that will help propel demand for nosocomial infection control equipment. Increasing prevalence of chronic diseases and rising advancements in surgical equipment are other factors that will drive sales of hospital acquired infection control systems.

Competitive Landscape
The healthcare industry has seen some major changes in the past few years, and healthcare-associated infections have gained a lot of attention due to a rise in their instances. Key players are trying to maximize their market potential with new launches and fortifying their research & developments to gain an edge over their competitors.

In April 2020, when the COVID-19 pandemic was peaking, demand for disinfection was more than ever. Allegheny Health Network (AHN), amidst this, announced a sterilization process that would allow the reuse of N95 masks that were very crucially in demand.
In July 2021, UVision360 Inc. announced that it had received approval for the expansion of reprocessing procedures for utilization with the LUMINELLE DTx System.

By Product Type:

Heat Sterilization Equipment
Moist Heat Sterilization Equipment
Dry Heat Sterilization Equipment
Low Temperature Sterilization Equipment
Radiation Sterilization Equipment
Disinfection Equipment
Washer Disinfectors
Flusher Disinfectors
Endoscopic Reprocessor Systems
Single Basin Endoscopic Reprocessor Systems
Dual Basin Endoscopic Reprocessor Systems
Disinfectants
By End User:

Hospital Acquired Infection Control Equipment for Hospitals
Hospital Acquired Infection Control Equipment for Ambulatory Surgical Centers
Hospital Acquired Infection Control Equipment for Diagnostic Laboratories
Hospital Acquired Infection Control Equipment for Clinics
Hospital Acquired Infection Control Equipment for Medical Institutions

Key questions answered in the report include:

who are the key market players in the Hospital-acquired infections (HAIs) Control Market?
Which are the major regions for dissimilar trades that are expected to eyewitness astonishing growth for the Hospital-acquired infections (HAIs) Control Market?
What are the regional growth trends and the leading revenue-generating regions for the Hospital-acquired infections (HAIs) Control Market?
What will be the market size and the growth rate by the end of the forecast period?
What are the key Hospital-acquired infections (HAIs) Control Market trends impacting the growth of the market?
What are the major Product Types of Hospital-acquired infections (HAIs) Control?
What are the major applications of Hospital-acquired infections (HAIs) Control?
Which Hospital-acquired infections (HAIs) Control Services technologies will top the market in next 7 years?

Please click here today to buy full report @ https://www.mraccuracyreports.com/checkout/379871

Hospital Acquired Infection Control Market Report Highlights
The consumables segment dominated the market and accounted for the largest revenue share of 47.0% in 2020. This was owing to the high usage of consumables in hospitals and ambulatory care centers. The COVID-19 pandemic further contributed to the segment share due to the increased need for disposable, safe, and effective solutions to curb the spread of the virus. These included products such as N95 masks, PPE, and gloves

The hospitals and Intensive Care Units (ICUs) segment held the largest revenue share of 46.0% in 2020 due to the high prevalence of healthcare-associated infections (HCAIs) in these facilities. According to CDC estimates, about 1 out of 31 hospital patients suffer from at least one HAI on any given day

In Asia Pacific, the market is anticipated to witness lucrative growth in coming years owing to increasing supportive government initiatives to promote HAIs control products in the region

Strategic initiatives by market players are mergers and acquisitions, collaboration, geographic expansions, and new product development. For example, in November 2020, Getinge acquired a manufacturer of decontamination products-Quadralene. The company was merged into Getinge's Infection Control portfolio to expand its offerings in the business area of Surgical Workflows

Table of Contents

Global Hospital-acquired infections (HAIs) Control Market Research Report 2022 - 2029

Chapter 1 Hospital-acquired infections (HAIs) Control Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Hospital-acquired infections (HAIs) Control Market Forecast

If you have any special requirements, please let us know and we will offer you the report as you want. you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Call Us - UK +44 7452119323
USA +1 8045001224
Email us - sales@mraccuracyreports.com
30 Crawley Lane, West Sussex, RH10 7EG, United Kingdom
3351 Green Turtle Rd, Regina, SK S4V 3N6, Canada

MR Accuracy Reports is a Market Research and consulting company that accomplishes requirement of research agencies,small, medium and large corporations, global business leaders, government organizations,
SME's, Individual & Start-ups, top management consulting firms

This release was published on openPR.